J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, F.
Right arrow Articles by Liu, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, F.
Right arrow Articles by Liu, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Lipid Research, Vol. 43, 1477-1485, September 2002
Copyright © 2002 by Lipid Research, Inc.

Identification of Egr1 as the oncostatin M-induced transcription activator that binds to sterol-independent regulatory element of human LDL receptor promoter

Fang Zhang, Thomas E. Ahlborn, Cong Li, Fredric B. Kraemer and Jingwen Liu1

Department of Veterans Affairs Palo Alto Health Care System, 3801 Miranda Avenue, Palo Alto, CA 94304

1 To whom correspondence should be addressed. e-mail: jingwen.liu{at}med.va.gov

Previously, we identified the low density lipoprotein receptor (LDLR) promoter region -17 to -1 as a novel sterol-independent regulatory element (SIRE) that mediates the stimulating effect of oncostatin M (OM). The goal of this study was to identify the OM-induced transcription activator that binds to the SIRE sequence. By conducting a electrophoretic mobility shift assay (EMSA) followed by UV crosslinking and SDS-PAGE, we show that a protein with a molecular mass of 85 kDa was present in the OM-induced SIRE DNA-protein complex. Western blotting and supershift assays reveal that the 85 kDa factor is early growth response gene 1 (Egr1). The interaction of Egr1 with the SIRE sequence was further confirmed in vivo by chromatin immunoprecipitation assays. The functional role of Egr1 in LDLR transcription was assessed by cotransfection of an Egr1 expression vector with an LDLR promoter reporter construct. We show that overexpression of Egr1 significantly increases LDLR promoter activity when cotransfected with CCAAT/enhancer binding protein ß (c/EBPß) or with cAMP-responsive element binding protein (CREB) expression vectors.

Our studies clearly demonstrate that Egr1 is the OM-induced transcription factor that binds to the SIRE sequence of the LDLR promoter and also suggest that Egr1 may have a functional role in OM-induced upregulation of LDLR transcription through interaction with other SIRE binding proteins such as c/EBPß or CREB.

Abbreviations: Ap1, activator protein 1; ATF, activating transcription factor; C/EBP, CCAAT/enhancer binding protein; CRE, cAMP-responsive element; CREB, cAMP-responsive element binding protein; Egr1, early growth response gene 1; EMSA, electrophoretic mobility shift assay; ERK, extracellular signal regulated kinase; LDLR, low density lipoprotein receptor; OM, oncostatin M; SIRE, sterol-independent regulatory element; SRE-1, sterol regulatory element-1; SREBP, SRE-1 binding protein

Supplementary key words cytokines • early growth response gene 1 • gene transcription • transcriptional activation • signal transduction


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Zhou, P. Abidi, A. Kim, W. Chen, T.-T. Huang, F. B. Kraemer, and J. Liu
Transcriptional Activation of Hepatic ACSL3 and ACSL5 by Oncostatin M Reduces Hypertriglyceridemia Through Enhanced {beta}-Oxidation
Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2198 - 2205.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
W. Kong, P. Abidi, F. B. Kraemer, J.-D. Jiang, and J. Liu
In vivo activities of cytokine oncostatin M in the regulation of plasma lipid levels
J. Lipid Res., June 1, 2005; 46(6): 1163 - 1171.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Morello, T. W.A. de Bruin, J. I. Rotter, R. E. Pratt, C. J.H. van der Kallen, G. A. Hladik, V. J. Dzau, C.-C. Liew, and Y.-D. I. Chen
Differential Gene Expression of Blood-Derived Cell Lines in Familial Combined Hyperlipidemia
Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2149 - 2154.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Zhang, M. Lin, P. Abidi, G. Thiel, and J. Liu
Specific Interaction of Egr1 and c/EBP{beta} Leads to the Transcriptional Activation of the Human Low Density Lipoprotein Receptor Gene
J. Biol. Chem., November 7, 2003; 278(45): 44246 - 44254.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.